Latham & Watkins Advised Theradaptive On Strategic Partnership With ATEC

Latham & Watkins Advised Theradaptive on Strategic Partnership With ATEC

Latham & Watkins has advised Theradaptive, Inc., a clinical-stage regenerative medicine company pioneering engineered protein therapeutics, on its strategic partnership with Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative solutions dedicated to revolutionizing spine surgery.

Under the terms of the agreement, ATEC gains exclusive US commercial rights to market and distribute Theradaptive's OsteoAdapt® osteoinductive bone graft for spinal fusion.

The Latham & Watkins team was led by London Oliver Mobasser (Counsel).

Click to know more about Latham & Watkins

If you have a news or deal publication or would like to collaborate on content, columns, or article publications, connect with the Legal Era News Network Team and email us at info@legalera.in or call us on +91 8879634922.